Skip to main content
Clinical Trials/NCT00219856
NCT00219856
Completed
Phase 3

Prospective, Randomized, Simple Blind Study Comparing the Effects of an Anaesthesia With Propofol to an Anaesthesia With Desflurane on Oxydative Stress and Liver Function Recovery After Hepatectomy

Rennes University Hospital1 site in 1 country34 target enrollmentAugust 2004

Overview

Phase
Phase 3
Intervention
Propofol
Conditions
Hepatectomy
Sponsor
Rennes University Hospital
Enrollment
34
Locations
1
Primary Endpoint
Plasma MDA levels
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Propofol is an anaesthetic agent that showed in vitro and in vivo anti oxidant properties. No data are available concerning the potential benefit of a total anaesthesia with propofol in partial hepatic surgery. Patients who undergo partial hepatic resection have frequent liver insufficiency that could be related in part to the oxidative stress induced by clamping the hepatic vessels during the surgical intervention. Our hypothesis is that propofol, by increasing liver resistance to this ischemia-reperfusion phenomenon, could improve the remaining liver function recovery, and therefore could reduce post surgical morbidity.

The aim of the study is to evaluate the anti oxidant effects of propofol compared to another widely used anaesthetic agent, inhaled desflurane, during and after partial hepatic resection with hepatic vessels clamping. The primary endpoint will be the level of malondialdehyde (a plasmatic marker of oxidative stress), 30 minutes after the end of hepatic clamping.

Detailed Description

Propofol is an anaesthetic agent that showed in vitro and in vivo anti oxidant properties. No data are available concerning the potential benefit of a total anaesthesia with propofol in partial hepatic surgery. Patients who undergo partial hepatic resection have frequent liver insufficiency that could be related in part to the oxidative stress induced by clamping the hepatic hilum during the surgical intervention. Our hypothesis is that propofol, by increasing liver resistance to ischemic-reperfusion injury, could improve the remaining liver function recovery, and therefore could reduce post surgical morbidity. The aim of the study is to evaluate the anti oxidant effects of propofol compared to another widely used anaesthetic agent, inhaled desflurane, during and after partial hepatic resection with hepatic hilum clamping. The primary endpoint will be the level of malondialdehyde (a plasmatic marker of oxidative stress), 30 minutes after the end of hepatic clamping. The evolution over time of other markers of oxidative stress will be studied (glutathione, myeloperoxidase, nitric oxide), as well as functional and biological markers of liver regeneration.

Registry
clinicaltrials.gov
Start Date
August 2004
End Date
March 2006
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rennes University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients over 18
  • Need for partial hepatic resection requiring heptic clamping
  • Resection of 4 liver segments or less
  • In case of cirrhosis, child A
  • Written informed consent
  • Non-inclusion Criteria:
  • Hemochromatosis
  • chemotherapy in the previous week before inclusion
  • Thrombosis of the portal vein or the hepatic artery
  • Absence of contraception among fertil woman

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Anesthesic induction and maintenance with intravenous propofol.

Intervention: Propofol

2

Anesthesic induction with intravenous penthotal and maintenance with inhaled desflurane.

Intervention: Penthotal

2

Anesthesic induction with intravenous penthotal and maintenance with inhaled desflurane.

Intervention: Desflurane

Outcomes

Primary Outcomes

Plasma MDA levels

Time Frame: 30 minutes after the end of hepatic clamping

Secondary Outcomes

  • Surgery related complications(10 days)
  • Kinetics of post surgical biological hepatic function recovery(Days 1, 2, 5, 10)
  • Kinetics of post surgical hepatic function recovery(Day 2)
  • Hemodynamics during and after surgery(Days 1 and 2)
  • Other biological markers of oxidative stress(Days 1 and 2)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane AnesthesiaBreast NeoplasmsColonic NeoplasmsRectal Neoplasms
NCT01975064Uppsala University5,774
Terminated
Not Applicable
Propofol Versus Volatile Anesthesia in Post Operative Pain ManagementVaricose VeinPostoperative Pain
NCT00712517The Cleveland Clinic90
Unknown
Phase 2
Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese PatientsMorbid Obesity
NCT01279499University of Patras100
Completed
Phase 4
Effects of Anesthesia With Propofol Versus Desflurane in Obese PatientsAnesthesiaObesity
NCT03417518Centre Hospitalier Universitaire Saint Pierre40
Active, not recruiting
Not Applicable
A randomized study to evaluate whether there is a difference in survival between two different forms of anaesthesia. The study will evaluate patients that are scheduled for a surgery for either breast-, colon- or rectalcancer.Patients with breast- or colorectal cancer that will undergo radical surgery for this cancer. During the surgery general aneasthesia with either propofol or sevoflurane will be used.MedDRA version: 14.1Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2013-002380-25-SECKF at Västmanlands hospital Västerås